BSE: STAR - Strides Pharma Science Limited

Rentabilidade por seis meses: -27.91%

Cronograma de promoção Strides Pharma Science Limited

Agenda avançada Gráfico simples
Financial Markets by TradingView

Sobre a empresa

Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, gels, powders, solids, ointments, and creams.

mais detalhes
It also develops branded generics products for the treatment of chronic therapies, including women's health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.
Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

EBITDA 3.77
EV/EBITDA 12.02
ISIN INE939A01011
Industry Pharmaceuticals
P/BV 1.06
P/E 75.66
P/S 1.02
Sector Health Care
Валюта inr
Валюта отчета inr
Выручка 27.07
Див.доход ао 0
Дивиденд ао 1.5
Сайт https://www.strides.com
Цена ао 1324.6
Число акций ао 0.0903 млрд
Alteração de preço por dia: +0.4362% (676.3)
Alteração de preço por semana: -0.738% (684.3)
Alteração de preço por mês: -55.54% (1527.7)
Alteração de preço em 3 meses: -51.81% (1409.6)
Mudança de preço em seis meses: -27.91% (942.2)
Mudança de preço por ano: +5.8% (642)
Mudança de preço em 3 anos: +62.44% (418.15)
Mudança de preço em 5 anos: +75.79% (386.4)
Mudança de preço em 10 anos: 0% (679.25)
Mudança de preço desde o início do ano: -1.6% (690.3)
Todos os parâmetros

Subestimação

Nome Significado Nota
P/S 1.76 8
P/BV 3.44 5
P/E 0 0
EV/EBITDA 22.91 5
Total: 5.5

Eficiência

Nome Significado Nota
ROA, % -1.13 0
ROE, % -3.26 0
Total: 0.6667

Dividendos

Nome Significado Nota
Div yield, % 0.0512 0.13
DSI 0.8571 8.57
Total: 1.79

Obrigação

Nome Significado Nota
Debt/EBITDA 11.07 0
Total: 5.8

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % 49.63 6
Rentabilidade Ebitda, % -46.65 0
Rentabilidade EPS, % -289.02 0
Total: 3.2
Mais detalhes

Supervisor Cargo Pagamento Ano de nascimento
Mr. Arun Kumar Pillai B.Com. Founder & Executive Chairperson 60M 1961 (64 ano)
Mr. Badree Komandur MD & Group CEO 44M 1972 (53 ano)
Ms. Manjula Ramamurthy Compliance Officer & Company Secretary N/A
Sormistha Ghosh Group General Counsel, Chief Risk Officer & Chief Sustainability Officer N/A
Mr. C. K. Sundar Executive Vice President of Operations N/A
Mr. Kevin P. Cook Senior Vice President of Strides Pharma Inc. N/A
Mr. P. V. S. Ramaraju Chief Operating Officer N/A
Mr. Aditya Arun Kumar Executive Director of Business Development & Director
Mr. Vikesh Kumar Group CFO & Chief Investor Relations Officer 1985 (40 anos)
Ms. Surabhi Loshali Group Chief Human Resource Officer 1980 (45 anos)

Endereço: India, Bengaluru, Strides House - abrir no Google Maps, abrir mapas Yandex
Site: https://www.strides.com